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Abstract Vacuole fusion requires Sec18p-dependent acylation
of the armadillo-repeat protein Vac8p that has been isolated
with cis-SNARE complexes. To gain more insight into the
mechanism of acylation, we analyzed the palmitoylation reac-
tion on isolated vacuoles or in vacuolar detergent extracts. Re-
combinant Vac8p is palmitoylated when added to vacuoles and
is anchored to membranes after modi¢cation. The palmitoyl
acyltransferase (PAT) extracted from vacuolar membranes is
functional in detergent extracts and shows all characteristics
of an enzymatic activity: It modi¢es exogenous Vac8p in a
temperature-, dose- and time-dependent manner, and is sensitive
to bromo-palmitate, a known inhibitor of protein palmitoylation
in vivo. Importantly, PAT is speci¢c for palmitoyl-CoA, since
myristoyl- and stearyl-CoA can compete with labeled Pal-CoA
only at 10-fold higher amounts.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Vacuole fusion; Vac8; Palmitoylation;
SNARE complex; Sec18
1. Introduction
Palmitoylation is the covalent attachment of fatty acids to
cysteine residues of membrane proteins. The fatty acids can
mediate protein^lipid and protein^protein interactions, there-
by targeting the modi¢ed protein to membranes or membrane
subdomains [1]. In general, four families of proteins exist that
are targets to palmitoylation: (1) proteins containing an
N-terminal myristic acid £anked by cysteines, (2) proteins
with a C-terminal prenylated Caax box, (3) proteins with a
cluster of cysteine residues in the middle of the molecule, and
(4) proteins that are modi¢ed proximal to their transmem-
brane domain. For most proteins palmitoylation is essential
for their function and occurs in the vicinity of a membrane [1].
It has been questioned whether enzymes were required for
acylation since some studies suggested that palmitoylation
might be a non-enzymatic event [2^4]. Only very recently,
the family of DHHC-CRD proteins (polytopic membrane
proteins with the sequence DHHC and a cysteine-rich do-
main) has been presented as potential acyltransferases for
proteins with a C-terminal Caax-box in yeast. Erf2p (in a
complex with Erf4p) appears to be necessary to mediate acyla-
tion of Ras, whereas Akr1p palmitoylates the C-terminal CC
sequence of the casein-kinase Yck2p [5^8]. Surprisingly, none
of the members of this family is essential for yeast growth. In
Drosophila, acylation of the homeobox protein hedgehog re-
quires the putative acyltransferase skinny hedgehog [9,10].
However, acylation of hedgehog occurs via an amide bond,
which makes it unlikely that skinny hedgehog is also respon-
sible for the more common mode of palmitoylation by thio-
ester bonding [11].
Activated fatty acids, the lipid substrates for protein palmi-
toylation, are involved in vesicular tra⁄cking. Pal-CoA stim-
ulates both the budding of transport vesicles from the Golgi
as well as the Golgi- and the yeast vacuole fusion assay [12^
15]. Using a non-hydrolyzable analog of Pal-CoA, it was sug-
gested that this stimulatory e¡ect might be due to palmitoy-
lation of proteins, which thereby get activated to function in
the fusion reaction [13]. Interestingly, Pal-CoA is most e¡ec-
tive at limiting NSF/Sec18p concentrations [12] indicating that
Pal-CoA and NSF/Sec18p act together in a step required for
protein transport and palmitoylation.
The yeast vacuole fusion assay is a model system to analyze
membrane tra⁄cking [16]. Vacuole fusion depends on a cas-
cade of events that can be divided into a priming, docking and
fusion step. During priming, ATP hydrolysis by Sec18p trig-
gers disassembly of a multisubunit SNARE complex into its
subunits [17], which is a prerequisite for docking and fusion
[18]. Using the yeast vacuole fusion assay we have recently
identi¢ed Vac8p as the ¢rst protein substrate of palmitoyla-
tion required for a vesicular tra⁄cking reaction [19,24]. Vac8p
was originally isolated as a protein involved in vacuole inher-
itance [20^23]. Vac8p is myristoylated cotranslationally at its
N-terminal glycine residue, and subsequently becomes palmi-
toylated at three neighboring cysteine residues [21,23]. Palmi-
toylation, but not myristoylation, is essential for vacuole in-
heritance, although both hydrophobic modi¢cations are
required for complete localization of Vac8p to the vacuole
[21]. During the yeast vacuole assay Vac8p becomes palmitoy-
lated only at the beginning of the reaction and palmitoylated
Vac8p is essential for vacuole fusion, probably acting at a
stage following trans-SNARE pairing [9,24]. So far, only
Sec18p has been identi¢ed to have a role in the palmitoylation
reaction, and might be involved in releasing cis-SNARE-
bound Vac8p, thus supplying the substrate for palmitoylation.
We have now established an in vitro assay to analyze the
acyltransferase in detail. PAT activity can be extracted from
vacuole membranes and can speci¢cally palmitoylate recombi-
nant Vac8p in detergent extracts. Speci¢city to Pal-CoA dem-
onstrates that substrate speci¢city appears to be one of its
important characteristics.
0014-5793 / 03 / $22.00 K 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
doi:10.1016/S0014-5793(03)00232-1
*Corresponding author. Fax: (49)-6221-544366.
E-mail address: cu2@ix.urz.uni-heidelberg.de (C. Ungermann).
FEBS 27103 25-3-03
FEBS 27103 FEBS Letters 540 (2003) 101^105
2. Materials and methods
2.1. Reagents and strain
[9,10-3H]Palmitic acid (50 Ci/mmol) was obtained from Hartmann
Analytic (Braunschweig, Germany). [3H]Pal-CoA was synthesized
with [3H]palmitate and acyl-CoA-synthetase as described in Section
2.4. 2-Bromo-palmitate was from ACROS, Belgium. All other re-
agents were purchased from Sigma. The yeast strains used in this
study were as described in [38,39]. Antibodies to Sec18p were made
to a recombinant bacterial-expressed protein [15]. When we added
recombinant Sec18p to vacuole fusion assays, antibodies to Sec18p
do not block fusion, nor palmitoylation, indicating that the antibody
has been quenched by the additional pure protein (our unpublished
observations).
2.2. Puri¢cation of Vac8-GST and His6-Vac8p from Escherichia coli
His6-Vac8p cloned into the pQE30 plasmid (N-terminal His6-tag on
Vac8p), was expressed in the absence of the human N-myristoyl-trans-
ferase (see below) and was puri¢ed as described in [19]. A PCR frag-
ment encoding Vac8p or Vac8C4;5;7A was cloned as a NcoI/NcoI frag-
ment into a pETGEX vector, thus generating a C-terminally tagged
Vac8-GST variant. The plasmids were transformed into an E. coli
XL1blue strain co-expressing the human N-myristoyl-transferase
(kindly provided by Roger Clegg, Hannah Research Institute, Ayr,
UK). NMT co-expression in E. coli leads to e⁄cient N-myristoylation
[40], although we have not analyzed the e⁄ciency of myristoylation of
Vac8-GST in our system. Vac8-GST and Vac8C4;5;7A-GST were puri-
¢ed with glutathione-agarose, eluted with 50 mM Tris^HCl, pH 7.4,
300 mM NaCl, 10 mM glutathione, and dialyzed into 10 mM PIPES/
KOH, pH 6.8 150 mM KCl, 5 mM MgCl2.
2.3. Labeling of the vacuole fusion assay
Palmitoylation of vacuoles with [3H]palmitate or [3H]Pal-CoA was
done as described except that recombinant His6-Vac8p (5 Wg) or
Vac8-GST were added [19]. Extraction of vacuoles with high salt or
TX-100 (Fig. 1d) was done as follows. Vacuolar pellets from an iden-
tical incubation were resuspended in 300 Wl high salt bu¡er (1 M KCl,
20 mM HEPES/KOH, pH 7.4, 1UPIC) and incubated for 15 min on
ice. Non-extracted material was pelleted (30 min, 20 000Ug) and the
supernatant was precipitated with trichloroacetic acid (TCA). The
pellet from the salt extraction was resuspended in Triton bu¡er
(0.1% Triton X-100, 50 mM KCl, 20 mM HEPES/KOH, pH 7.4)
and incubated for 15 min. Non-extracted material was again pelleted
and the pellet and the TCA-precipitated supernatant were analyzed by
sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and £uorography.
2.4. E¡ect of 2-bromo-palmitate on acyl-CoA synthesis
Acyl-CoA synthetase (2 Wl, 10 mg/ml in phosphate bu¡er, from
Pseudomonas fragi, 20 units in 2.8 mg of protein, Roche) was incu-
bated for 10 min at 28‡C in glass vessels with coenzyme A (3 Wl, 10
mM in distilled water), [3H]palmitic acid (25 WCi, 50^60 Ci/mmol,
dissolved in 5 Wl ethanol), 1 mM ATP, and 4 mM MgSO4 in a ¢nal
volume of 50 Wl phosphate bu¡er (pH 7.4). Br-Pal (1 Wl) was added
from a 50U concentrated stock solution in ethanol. The reaction was
stopped by adding 500 Wl acetonitrile/1 M phosphoric acid (9:1) and
precipitated proteins were pelleted (10 min, 5000Ug). The supernatant
was extracted three times with 1 ml of toluol to remove the remaining
[3H]palmitic acid. Aliquots of the lower phase, which contains
[3H]Pal-CoA, were counted in a liquid scintillation counter.
2.5. Palmitoylation assay
Unless mentioned otherwise, BJ3505 vacuoles were preincubated
under fusion conditions for 15 min at 30‡C. Vacuoles were pelleted
(10 min, 12 000Ug), resuspended in PS bu¡er (10 mM PIPES/KOH,
pH 6.8, 200 mM sorbitol) containing 0.5U PIC (protease inhibitor
cocktail: 7.5 WM pefabloc SC, 7.5 ng/ml leupeptin, 3.75 WM o-phen-
anthroline and 37.5 ng/ml pepstatin) and again pelleted. Membranes
from a 200 Wl reaction were solubilized in 100 Wl Triton bu¡er (0.25%
Triton X-100, 50 mM KCl, 20 mM HEPES/KOH pH 7.4 and 1U
PIC) and incubated for one h at 4‡C with agitation. Insoluble material
was pelleted (15 min, 20 000Ug) and the supernatant was used imme-
diately in the PAT assay or stored at 380‡C. Where indicated, vac-
uoles were extracted with 1 M KCl, 20 mM HEPES/KOH, pH 7.4.
Vacuolar extract (10 Wl, about 5 Wg) was incubated with Vac8-GST
and [3H]Pal-CoA in 20 mM PIPES, pH 6.8, 120 mM KCl in a ¢nal
volume of 100 Wl for 15 min at 30‡C. 1 ml of chloroform/methanol
(1:2) was added and precipitated proteins were pelleted at 10 000Ug
for 5 min. The pellet was washed with 1 ml of methanol and again
centrifuged. Proteins were resuspended in non-reducing sample bu¡er
and subjected to SDS^PAGE and £uorography.
3. Results
3.1. Speci¢c palmitoylation of recombinant Vac8p
We sought to bypass the association of endogenous Vac8p
with the SNARE complex by using soluble Vac8p as substrate
for palmitoylation. When added to the vacuole fusion reac-
tion, recombinant Vac8p with an N-terminal His-tag (His6-
Vac8p) was palmitoylated in a concentration-dependent man-
ner (Fig. 1a). Palmitoylation requires ATP and CoA, but not
cytosol, demonstrating that the PAT activity is likely to reside
on the vacuole. ATP and CoA are required for the synthesis
of Pal-CoA from [3H]palmitate. The palmitoyl-transfer reac-
tion analyzed with the vacuolar extract and [3H]Pal-CoA as
Fig. 1. Yeast vacuoles palmitoylate exogenous Vac8p. a: E⁄cient
palmitoylation of exogenous Vac8p. Vacuole fusion reactions (60 Wg
vacuoles in 300 Wl) containing cytosol (0.5 Wg/Wl), coenzyme A (10
WM) and ATP (100 WM) as indicated were supplemented with re-
combinant His6-Vac8p and [3H]palmitate (150 WCi) and incubated
for 20 min at 30‡C. Vacuoles were then pelleted, washed and sub-
jected to non-reducing SDS^PAGE and £uorography. b: Labeling
of exogenous Vac8p occurs early. Vacuole fusion reactions contain-
ing cytosol, ATP and CoA were started and 0, 5, 10, 20 or 40 min
later 5 Wg His6-Vac8p and [3H]palmitate were added and incuba-
tions were continued for 15 min. Analysis was done as in panel a.
c: A fraction of exogenous Vac8p is found on vacuoles after palmi-
toylation. Vacuole fusion reactions containing cytosol, ATP, CoA
and 5 Wg His6-Vac8p were incubated for 15 min at 30‡C. Vacuoles
were pelleted and washed twice with PS bu¡er. The supernatant
was precipitated with 13% (v/v) TCA, washed with ethanol and re-
suspended in reducing sample bu¡er. Supernatant (20%, lane 2) and
the complete vacuolar pellet (lane 1) were applied to SDS^PAGE.
In a parallel experiment, vacuoles were salt-extracted (see Section 2)
and the initial amount of vacuole (vac, lane 3), the complete super-
natant (S, lane 4) and the vacuolar pellet (P, lane 5) were analyzed
by Western blotting with anti-His antibodies (Qiagen). d: Exoge-
nous Vac8p associated with vacuoles is palmitoylated. Vacuole fu-
sion reactions supplemented with 5 Wg His6-Vac8p and
[3H]palmitate were incubated for 15 min. Vacuoles were then pel-
leted, washed, and directly solubilized in SDS^PAGE bu¡er (vac),
extracted with high salt or Triton X-100. Supernatants (S) and pel-
lets (P) were then subjected to SDS^PAGE and £uorography.
e: Antibodies to Sec18p block acylation of exogenous Vac8p. Vacuole
fusion reactions containing 5 Wg His6-Vac8p were incubated as be-
fore. Where indicated, antibodies of Sec18p were added. Analysis
was as in panel a.
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substrates (see below) does not depend on ATP and CoA
(Dietrich et al., submitted). When we added His6-Vac8p at
di¡erent times to the fusion reaction, [3H]-labeling was ob-
served only early in the reaction (Fig. 1b), similar to our
observations with the endogenous protein [19]. This indicates
that the PAT must be activated on isolated vacuoles. Alter-
natively, it is also possible that His6-Vac8p must be positioned
on the vacuole such that acylation can occur. To show that
exogenous Vac8p was indeed membrane-associated, we la-
beled His6-Vac8p with [3H]palmitate and localized it on vac-
uole membranes. Only 5% of His6-Vac8p was membrane-
bound and largely extracted by salt treatment as revealed by
Western blotting (Fig. 1c). This loose association with the
membrane also occurs during incubation on ice (not shown),
indicating that enzymatic events are not required for binding.
However, tritium-labeled His6-Vac8p was exclusively recov-
ered with membranes and required detergent for extraction
(Fig. 1d). Moreover, the acylation of His6-Vac8p shows the
same requirements as palmitoylation of endogenous Vac8p
[19] : antibodies to Sec18p inhibit labeling of His6-Vac8p
when added to the fusion reaction (Fig. 1e).
3.2. Extraction of PAT from vacuolar membranes
To establish an assay that measures PAT activity we gen-
erated a C-terminally tagged Vac8-GST fusion protein, which,
due to its higher molecular weight, separates during SDS^
PAGE from endogenous Vac8p. We prepared Vac8-GST in
the presence of the human N-myristoyl transferase from E. coli
(see Section 2). Vacuoles e⁄ciently palmitoylate Vac8-GST
using [3H]Pal-CoA as a lipid donor, whereas a similar con-
struct with alanine substitutions in the N-terminal cysteines
did not get modi¢ed (Fig. 2a). Since non-myristoylated His6-
Vac8p and myristoylated Vac8-GST are equally labeled, we
assume that the myristoyl anchor may be dispensable for in
vitro labeling, possibly due to the excess amount of the added
protein. The anchor is, however, essential for in vivo targeting
to the vacuole [21]. To prepare extracts with palmitoylating
activity from vacuole membranes, we preincubated vacuoles
in the presence of ATP at 26‡C to allow SNARE-complex
disassembly. Vacuoles were then collected by centrifugation,
solubilized in Triton X-100 or extracted with high salt. The
resulting extracts were incubated with [3H]Pal-CoA and with
or without Vac8-GST. Proteins were then precipitated with
chloroform/methanol to remove non-covalently bound fatty
acids and subjected to SDS^PAGE and £uorography. In the
presence of detergent alone we were able to extract PAT ac-
tivity, indicating that the activity is membrane-associated (Fig.
2b). We then conducted several control experiments to char-
acterize the activity. Palmitoylation increases with increasing
concentrations of substrate and membrane extract (Fig. 2c).
Preincubation of vacuoles with anti-Sec18p prior to extraction
abolished recovery of PAT, indicating that Sec18p is proximal
to PAT on the vacuole. No labeling of Vac8p was seen in the
absence of the extract, indicating that non-enzymatic palmi-
toylation does not occur under these conditions. Labeling of
Vac8p was complete after 10 min and was best at 30‡C, sim-
ilar to our observations with endogenous Vac8p (Fig. 2d,e;
[19]). In contrast, non-enzymatic palmitoylation usually re-
quires several hours before completion [3]. In addition, heat-
ing of Vac8p or the extract, as well as trypsin addition to the
extract prior to addition to the in vitro assay abolished acy-
lation, indicating that the PAT is a protein (Fig. 2f). Further-
more, a mutant of Vac8p with alanine substitutions in the
three N-terminal cysteine residues is not labeled, indicating
that palmitoylation occurs at the same sites that are acylated
in vivo (Fig. 2f).
3.3. Inhibitors and speci¢city of the acylation reaction
The fatty acid analog 2-bromo-palmitate (Br-Pal) is known
to inhibit protein palmitoylation in vivo and in vitro when
labeling is done with [3H]palmitate. Br-Pal could therefore
inhibit either the synthesis of activated fatty acids by acyl-
CoA synthetase or the transfer of the activated fatty acid by
PAT, or both. To understand its precise mode of inhibition,
we analyzed the e¡ect of Br-Pal on acyl-CoA synthesis. Puri-
¢ed acyl-CoA synthetase (from P. fragi) was incubated with
[3H]palmitate, CoA, ATP and increasing concentrations of
Br-Pal, and synthesized [3H]Pal-CoA was extracted and
counted. Br-Pal blocked Pal-CoA synthesis completely at
100 WM (Fig. 3a). Similarly, the same concentration of Br-
Pal was su⁄cient to block acyl-CoA synthesis on isolated
Fig. 2. Reconstitution of the PAT activity in vacuolar detergent ex-
tracts. a: Acylation of Vac8-GST. Vacuole fusion reactions contain-
ing cytosol and ATP were incubated with 10 nM [3H]Pal-CoA and
increasing concentrations of Vac8-GST for 15 min. Lane 4 contains
a Vac8-GST mutant (C4;5;7A) with a deletion of its palmitoylation
sites (Cys3). b: Extraction of acyltransferase activity from vacuoles.
Vacuoles (120 Wg) were incubated with ATP (100 WM) and cytosol
(0.5 Wg/Wl) for 15 min under fusion conditions. One sample con-
tained antibodies against Sec18p (30 Wl). Vacuoles were then pel-
leted, washed and extracted with Triton X-100 or high salt (see Sec-
tion 2). Non-soluble material was pelleted and 5 Wg (10 Wl) of the
supernatant was incubated with 3 Wg Vac8-GST and 30 nM
[3H]Pal-CoA for 15 min at 30‡C. Proteins were then extracted with
chloroform/methanol, precipitated and subjected to SDS^PAGE and
£uorography. c: Dose-dependent acylation. Increasing concentra-
tions of the Triton extract and of Vac8-GST were incubated with
[3H]Pal-CoA for 15 min. d: Time course of acylation. Triton ex-
tracts (5 Wg) were incubated with 7 Wg Vac8-GST for the times indi-
cated. e: Temperature optimum of acylation. The Triton extract
(5 Wg) was incubated with 5 Wg Vac8-GST on ice or at the tempera-
tures indicated. f : The acyltransferase activity is proteinaceous.
Samples were preincubated as follows: Vac8-GST (lane 1) or the ex-
tract (lane 3) were heated at 95‡C for 3 min prior to addition to
the assay. For the trypsin digestion, 10 Wl of the extract was incuba-
ted with 1 Wl trypsin (1.5 Wg/Wl) for 30 min at 37‡C, then 1 Wl tryp-
sin inhibitor (10 Wg/Wl) was added. Control samples received trypsin
and trypsin inhibitor at the same time (lanes 4 and 5). To analyze
the speci¢city of acylation (lanes 6^8), the Triton X-100 extract was
incubated with 5 Wg of wild-type Vac8-GST (Cysþ) or a mutant
with a deletion of its palmitoylation sites (Cys3). Lane 6 does not
contain Vac8-GST.
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vacuoles (Fig. 3b), demonstrating that the synthesis of Pal-
CoA is blocked by Br-Pal. In addition, Br-Pal also interferes
with the transfer of fatty acids. When Vac8-GST was incuba-
ted with the detergent extract and [3H]Pal-CoA, Br-Pal inhib-
ited acylation of Vac8p completely (Fig. 3c). Thus, Br-Pal
inhibits both Pal-CoA synthesis and fatty acid transfer. If
Br-Pal would block the transfer by possibly binding to a
Pal-CoA binding pocket within the acyltransferase, we would
expect that the PAT should be able to discriminate between
several acyl-CoA analogs. Indeed, cold Pal-CoA e⁄ciently
inhibited transfer of [3H]Pal-CoA to Vac8p, whereas Myr-
CoA (C14) or stearyl-CoA (C18) did so only at a 10-fold high-
er concentration (Fig. 4). This indicates that the vacuolar
PAT may have su⁄cient speci¢city to recognize the length
of the acyl chain prior to transfer to Vac8p.
4. Discussion
Our study shows that the yeast vacuolar membrane con-
tains a palmitoylating activity (PAT), which can be extracted
with detergent, but not with high salt. The latter ¢nding is
consistent with all published studies describing a PAT activity
[25^28] and indicates that PAT closely associates with the
membrane, either via a transmembrane region or by a hydro-
phobic modi¢cation. Our data reveal that the vacuolar PAT
ful¢lls all criteria of an enzyme: (i) it is protease-sensitive,
(ii) has a temperature optimum, (iii) modi¢es its natural sub-
strate Vac8p in a time- and dose-dependent manner and at its
previously identi¢ed palmitoylation sites, and (iv) the activity
is blocked by the palmitoylation inhibitor Br-Pal. The vacuo-
lar PAT shows 10-fold higher speci¢city for Pal-CoA com-
pared to other activated fatty acids, e.g. Myr-CoA and
Stear-CoA. The combination of these data excludes that we
are dealing with an uncatalyzed, non-enzymatic reaction,
which has been described for some proteins in vitro [3,29].
Identi¢cation of palmitoyl acyltransferases has been di⁄cult
due to the instability of the enzyme. Recently, proteins of the
DHHC-cysteine-rich domain proteins (DHHC-CRD) have
been implicated as acyltransferases for palmitoylation at the
C-terminus of target proteins. Erf2p (in a complex with Erf4p)
is involved in palmitoylation of yeast Ras whereas Akr1p
palmitoylates the casein-kinase Yck2p [7,8]. In vitro reconsti-
tution and mutations of the histidine or cysteine residues of
Erf2p and Akr1p suggest a direct role of these proteins in
acylation. Erf4p may act as a chaperone for Erf2p [7]. Sim-
ilarly, Sec18p might cooperate with the vacuolar PAT to pro-
mote palmitoylation. The identi¢cation of the vacuolar PAT
may provide details of this interaction.
Interestingly, the Erf2/4 complex is speci¢c for Ras2p and
only little acylation is observed with N-myristoylated Gpa1p,
the K-subunit of the trimeric GTPase of the yeast plasma
membrane. Likewise, acylation of Ras2p is unimpaired in cells
lacking Akr1p. Furthermore, Erf2/4 localize to the ER and
Akr1p to the Golgi and endosomes. In yeast, seven DHHC
proteins have been identi¢ed by sequence comparison. All are
non-essential, though it is possible that they have overlapping
function. No DHHC-CRD protein seems to be required for
maintaining vacuole morphology [30]. In contrast, yeast cells
carrying a mutant of Vac8p with alanine substitutions for the
palmitoylated cysteines have the same multilobed vacuoles
observed for cells lacking Vac8p altogether. We there consider
it unlikely that a DHHC family member is identical to the
vacuolar PAT.
Vac8p is a myristoylated protein required for vacuole fusion
and inheritance [20^23,31]. We have previously shown that
acylation of Vac8p is an early event in vacuole fusion and
inhibited by antibodies to Sec18p. A portion of endogenous
Vac8p is associated with the vacuolar SNARE complex, and
Vac8p is separated from the SNAREs during Sec18p/ATP-
dependent priming [19]. The actual function of Sec18p is,
however, unclear in this reaction, since palmitoylation is not
ATP-dependent (Dietrich et al., submitted). Only recently, a
novel function of the Sec18p homolog NSF has been de-
scribed. NSF activates fusion of post-mitotic Golgi mem-
branes in an ATP hydrolysis-independent manner [32], by
associating with the SNARE GOS-28 together with GATE-
16 and K-SNAP prior to fusion [33]. Additional functions of
NSF in the activation of the glutamate receptor at the post-
Fig. 3. Br-Pal and cold acyl-CoAs inhibit fatty acid transfer. a: In-
hibition of acyl-CoA synthetase by Br-Pal. Puri¢ed acyl-CoA syn-
thetase was incubated with [3H]palmitate and increasing concentra-
tions of Br-Pal. Non-converted [3H]palmitate was then extracted
and synthesized [3H]Pal-CoA was counted (see Section 2 for details).
The mean of four experiments including the standard error is
shown. b: TLC analysis. Vacuole fusion reactions were labeled with
[3H]palmitate for 15 min in the absence or presence of Br-Pal. Lip-
ids were extracted and analyzed by TLC and £uorography.
PL=phospholipids, FA= free fatty acids. c: Inhibition of acyltrans-
ferase activity by Br-Pal. The Triton extract (7.5 Wg) was incubated
with 5 Wg Vac8-GST. [3H]Pal-CoA and increasing concentrations of
Br-Pal (1 Wl of a 100U stock solution in ethanol) for 30 min at
30‡C.
Fig. 4. Lipid speci¢city of the vacuolar acyltransferase. Triton ex-
tracts were incubated with [3H]Pal-CoA (20 nM) and cold Myr-
CoA, Pal-CoA or Stear-CoA (added from a 100U stock solution in
water) as indicated.
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synapse are also known [34^37]. We are presently character-
izing the acyltransferase to unravel the precise role of Sec18p
in this process.
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